NASDAQ:AIFF Firefly Neuroscience (AIFF) Stock Price, News & Analysis $1.36 -0.10 (-6.85%) Closing price 10/2/2026 04:00 PM EasternExtended Trading$1.40 +0.04 (+2.87%) As of 10/2/2026 07:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOwnershipSEC Filings About Firefly Neuroscience Stock (NASDAQ:AIFF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Firefly Neuroscience alerts:Sign Up Key Stats Today's Range$1.31▼$1.4750-Day Range$0.93▼$2.0152-Week Range$0.62▼$3.15Volume705,575 shsAverage Volume8.25 million shsMarket Capitalization$21.34 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Firefly Neuroscience, Inc. is a medical technology company focused on applying artificial intelligence to brain health and neurological care. The company develops software designed to analyze electroencephalography (EEG) data and identify objective patterns associated with cognitive and mental health conditions. Its principal offering is the Brain Network Analytics (BNA) platform, which uses machine-learning algorithms to evaluate brain activity and generate biomarkers intended to support the assessment, monitoring and management of conditions such as cognitive impairment and depression. The platform is designed to help clinicians complement conventional evaluations with data-driven insights into brain function. Firefly Neuroscience serves healthcare providers, researchers and other organizations involved in neuroscience and mental health. The company’s technology is focused primarily on clinical and research applications, although specific geographic markets and commercial partnerships may evolve as adoption expands. Firefly Neuroscience is led by Chief Executive Officer Jon Olsen.AI Generated. May Contain Errors. Read More Firefly Neuroscience Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks14th Percentile Overall ScoreAIFF MarketRank™: Firefly Neuroscience scored higher than 14% of companies evaluated by MarketBeat, and ranked 825th out of 887 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingFirefly Neuroscience has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageFirefly Neuroscience has only been the subject of 1 research reports in the past 90 days.Read more about Firefly Neuroscience's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Firefly Neuroscience is -2.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Firefly Neuroscience is -2.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioFirefly Neuroscience has a P/B Ratio of 2.39. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.06% of the float of Firefly Neuroscience has been sold short.Short Interest Ratio / Days to CoverFirefly Neuroscience has a short interest ratio ("days to cover") of 4.96.Change versus previous monthShort interest in Firefly Neuroscience has recently decreased by 28.74%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldFirefly Neuroscience does not currently pay a dividend.Dividend GrowthFirefly Neuroscience does not have a long track record of dividend growth. News and Social Media3.2 / 5News Sentiment0.14 News SentimentFirefly Neuroscience has a news sentiment score of 0.14. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.47 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Firefly Neuroscience this week, compared to 2 articles on an average week.Search Interest6 people have searched for AIFF on MarketBeat in the last 30 days. This is an increase of 500% compared to the previous 30 days.MarketBeat Follows1 people have added Firefly Neuroscience to their MarketBeat watchlist in the last 30 days. Company Ownership0.3 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Firefly Neuroscience insiders have not sold or bought any company stock.Percentage Held by Insiders6.90% of the stock of Firefly Neuroscience is held by insiders.Percentage Held by Institutions4.96% of the stock of Firefly Neuroscience is held by institutions.Read more about Firefly Neuroscience's insider trading history. Receive AIFF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Firefly Neuroscience and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AIFF Stock News HeadlinesPenny Stocks To Follow Today - September 27thSeptember 29, 2026 | americanbankingnews.comPenny Stocks To Research - September 25thSeptember 28, 2026 | americanbankingnews.comRay Dalio: Buy Gold. Get Paid.Ray Dalio, founder of Bridgewater Associates, is urging investors to hold 15% of their portfolio in gold and crypto as U.S. debt continues to climb and fiat currencies lose purchasing power. A little-known $15 fund is already converting gold's momentum into monthly income - as much as $1,152 per month. No gold bars, no mining stocks, just consistent payouts.October 4 at 1:00 AM | Investors Alley (Ad)Penny Stocks To Watch Today - September 26thSeptember 28, 2026 | americanbankingnews.comA Drug-Free ADHD Treatment for Kids Gets a Brain-Scan Network Behind ItSeptember 26, 2026 | msn.comFirefly Collaborates With NeuroSigma On Promoting Device For Pediatric ADHD; Stock Surges Over 25%September 26, 2026 | rttnews.comFirefly Neuroscience, Inc. And NeuroSigma, Inc. Partner To Expand Access To First FDA-Cleared, Non-Drug Treatment For Pediatric ADHDSeptember 25, 2026 | marketscreener.comMFirefly Hikes on Partnering with NeuroSigmaSeptember 25, 2026 | baystreet.caSee More Headlines AIFF Stock Analysis - Frequently Asked Questions How have AIFF shares performed this year? Firefly Neuroscience's stock was trading at $0.8750 on January 1st, 2026. Since then, AIFF shares have increased by 55.4% and is now trading at $1.36. How were Firefly Neuroscience's earnings last quarter? Firefly Neuroscience, Inc. (NASDAQ:AIFF) issued its quarterly earnings data on Monday, August, 10th. The company reported ($0.10) earnings per share for the quarter. The company had revenue of $0.51 million for the quarter. Firefly Neuroscience had a negative net margin of 506.23% and a negative trailing twelve-month return on equity of 90.17%. When did Firefly Neuroscience's stock split? Firefly Neuroscience's stock reverse split before market open on Tuesday, August 13th 2024.The 1-3 reverse split was announced on Friday, August 9th 2024. The number of shares owned by shareholders was adjusted after the market closes on Monday, August 12th 2024. An investor that had 100 shares of stock prior to the reverse split would have 33 shares after the split. How do I buy shares of Firefly Neuroscience? Shares of AIFF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Firefly Neuroscience own? Based on aggregate information from My MarketBeat watchlists, some other companies that Firefly Neuroscience investors own include Broadcom (AVGO), Paylocity (PCTY), Analog Devices (ADI), Advanced Micro Devices (AMD), ASML (ASML), Baidu (BIDU) and Bruker (BRKR). Company Calendar Last Earnings8/10/2026Today10/04/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1w+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 For the last 9 days, AIFF's financial health has been in the Green zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Technology Sub-IndustryHealthcare Technology Current SymbolNASDAQ:AIFF Previous SymbolNASDAQ:AIFF CIK803578 Webfireflyneuro.com Phone(888) 237-6412Fax703-293-7979Employees17Year FoundedN/AProfitability EPS (Trailing Twelve Months)($0.59) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$19.88 million Net Margins-506.23% Pretax Margin-506.17% Return on Equity-90.17% Return on Assets-72.05% Debt Debt-to-Equity RatioN/A Current Ratio4.87 Quick Ratio4.85 Sales & Book Value Annual Sales$1.14 million Price / Sales18.72 Cash FlowN/A Price / Cash FlowN/A Book Value$0.57 per share Price / Book2.39Miscellaneous Outstanding Shares15,690,000Free Float14,607,000Market Cap$21.34 million OptionableN/A Beta0.51 Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (NASDAQ:AIFF) was last updated on 10/4/2026 by MarketBeat.com Staff. From Our PartnersRay Dalio: Buy Gold. Get Paid.Ray Dalio, founder of Bridgewater Associates, is urging investors to hold 15% of their portfolio in gold and c...Investors Alley | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredElon Warns "America Will Go Bankrupt". Trump's Plan Inside.National debt just crossed 40 trillion dollars, and Elon Musk says America is 1,000% going to go bankrupt with...American Hartford Gold | SponsoredHow options let you do more with less capitalWould you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fractio...Base Camp Trading | SponsoredFree Stock: Economist calls it “the world’s most important machine.”Nvidia's most expensive chip component isn't made by Nvidia. Jeff Brown, former semiconductor executive, says ...Brownstone Research | SponsoredThe case for $20,000 gold before year endPresident Trump reposted a warning from precious metals expert Jim Rickards, tying the November midterms and A...Stansberry Research | SponsoredA major gold reset could be closer than people thinkFor 50 years, Washington has held 8,133 tonnes of gold on its books at a fraction of today's market price. One...Reagan Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Firefly Neuroscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Firefly Neuroscience With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
